Shire subsidiaries settled litigation with Actavis and Watson Laboratories

Pharmaceuticals group Shire has said its subsidiary Shire LLC, has settled all pending litigation with Actavis and Watson Laboratories.

Pharmaceuticals group Shire has said its subsidiary Shire LLC, has settled all pending litigation with Actavis and Watson Laboratories.

The litigation was in relation Actavis and Watson's abbreviated new drug applications (ANDAs) for generic versions of Shire's Intuniv product for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

The settlement provides Actavis with a licence to make and market its generic versions of Intuniv in the US on December 1st 2014, and any sales will results in royalty payments of 25% of gross profits to Shire during the 180 day exclusivity period.

The settlement also provides Watson with a licence to make and market Watson's generic versions of Intuniv in the US 181 days after Actacis's own launch.

NR

Recommended

Broker safety – your questions answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
How demographics affects stock valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Do you own shares in Sirius Minerals? Here’s what you need to do now
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020

Most Popular

Why we won’t see a house-price crash in 2021
House prices

Why we won’t see a house-price crash in 2021

Lockdown sent house prices berserk as cooped up home-workers fled for bigger properties in the country. And while they won’t rise quite as much this y…
18 Jan 2021
The world’s fund managers are getting very bullish – be careful out there
Stockmarkets

The world’s fund managers are getting very bullish – be careful out there

The latest survey of fund managers shows them to be extremely bullish on all the same things. And that, says John Stepek, means the market is in dange…
21 Jan 2021
Prepare for the end of the epic bubble in US stocks
US stockmarkets

Prepare for the end of the epic bubble in US stocks

US stocks are as expensive as they’ve ever been. How can you prepare your portfolio for a bubble bursting?
18 Jan 2021